Skip to main content

Shock the world: Startup snares $22M for plan to democratize defibrillation

The company's automated external defibrillator is under review by the FDA, but its leaders hope to have the device on the market by the end of the year.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.